The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBPKD.L Regulatory News (BPKD)

  • There is currently no data for BPKD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Purchase of significant holding of shares in Bank

8 Dec 2016 11:36

RNS Number : 3420R
Bank Pekao S.A.
08 December 2016
 

 

UNOFFICIAL TRANSLATION

 

Report 29/2016: Information of Powszechny Zakład Ubezpieczeń S.A. on conclusion of a transaction of the purchase of a significant holding of shares in Bank Polska Kasa Opieki S.A by PZU SA acting in a consortium with Polski Fundusz Rozwoju S.A. from UniCredit S.p.A.

 

The Management Board of Bank Polska Kasa Opieki S.A. with its registered office in Warsaw ("Bank", the "Company"), acting on the basis of Art. 17 sec. 1 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC (Official Journal of the European Union L of 2014, No. 173, p. 1, as amended, hereinafter referred to as the "MAR"), hereby informs that on 8 December, 2016 Powszechny Zakład Ubezpieczeń ("PZU") announced by current report No 82/2016:

 

"

Conclusion of negotiations with UniCredit S.p.A., obtaining of corporate authorisations for acquisition of shares in Bank Pekao S.A. and Pioneer Pekao Investment Management S.A. (and through this, indirectly, Pioneer Pekao TFI S.A.), Pekao Pioneer PTE S.A. and Dom Inwestycyjny Xelion Sp. z o.o., and entering into consortium agreement and shareholders' agreement with PFR S.A. along with conclusion of share purchase agreement regarding Bank Pekao S.A. and consortium agreement with PFR S.A.

 

Legal basis: Art. 17 section 1 of MAR - confidential information

 

The Management Board of Powszechny Zakład Ubezpieczeń Spółka Akcyjna with its registered office in Warsaw ("PZU SA", the "Company"), acting on the basis of Art. 17 sec. 1 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC (Official Journal of the European Union L of 2014, No. 173, p. 1, as amended, hereinafter referred to as the "MAR"), hereby informs that negotiations aimed at the conclusion of a transaction of the purchase of a significant holding of shares in Bank Polska Kasa Opieki S.A. (the "Bank") by PZU SA acting in a consortium with Polski Fundusz Rozwoju S.A. ("PFR") from UniCredit S.p.A. (the "Seller", "UniCredit", PZU SA, PFR and the Seller are jointly referred to as the "Parties"), about the conducting of which the Company informed in current report No. 68/2016, were concluded.

 

At the same time, the Management Board and Supervisory Board of PZU SA granted consents to the conclusion of an agreement on the sale of a block of the Bank's shares (the "SPA") and other agreements required to carry out the planned transaction.

 

Subsequently, on 8 December 2016, PZU SA and PFR concluded the SPA with UniCredit.

 

The substance of the transaction provided for in the SPA is the acquisition by PZU SA and PFR, acting in concert, of a significant (ultimately covering approx. 32.8% of the total number of votes) block of the Bank's shares. The transaction will be completed in two stages. In the first stage PZU SA will acquire from the Seller 100% of the shares in a special purpose company (the "SPV") which will be the owner of the Bank's shares in a number representing approx. 20% of the total number of votes, and simultaneously, PFR will directly acquire a block of shares representing approx. 10% of the total number of votes. In the second stage, implemented not sooner than 60 days after the first acquisition, PFR will directly acquire the

remaining block of the Bank's shares covered by the SPA representing approx. 2.8% of the total number of votes (jointly, the "Transaction").

 

The price agreed by the Parties is PLN 123 (one hundred twenty three zloty) per share, which implies a total price of PLN 10 589 091 156 (ten billion five hundred eighty nine million ninety one thousand one hundred fifty six zloty) for the entire block of shares being acquired by PZU SA and PFR, including a price of PLN 6 456 762 861 (six billion four hundred fifty six million seven hundred sixty two thousand eight hundred sixty one zloty) for the block of shares being acquired by PZU SA. As a rule, SPA does not provide for an adjustment of the purchase price, save for an automatic reduction of the total sale price by the value of the dividends paid to the Seller.

 

The completion of the Transaction is conditional on fulfilment of certain conditions precedent provided for in the SPA which include, in particular: (i) obtaining of the consents of the antimonopoly authorities in Poland and Ukraine and (ii) also obtaining by the Seller and PZU SA and PFR of the relevant consents or decisions from the PFSA. Pursuant to the SPA, the conditions must be fulfilled prior to the long stop date, which has been agreed, as a rule, for the first anniversary of signing of the SPA, i.e. 8 December 2017. In the event the conditions are not fulfilled or waived in accordance with the SPA, each of the Parties will have the right

to rescind the SPA, which will result in withdrawal from the Transaction on the terms set out in the SPA.

 

PZU SA will publicly disclose information about the fulfilment or failure to fulfil the above indicated conditions of the Transaction in current reports.

 

The SPA contains a certain list of representations and warranties on the part of the Seller with respect to the shares being sold and with respect to the business situation and condition of the Bank and other entities from the Bank's capital group. Moreover, the SPA provides for the indemnification of PZU SA and PFR against any losses arising due to regulatory changes that affect the Bank's existing credit portfolio denominated in CHF. The Parties agreed that the above indemnification will not exceed an agreed amount and will in general be available for PZU SA and PFR for a period of 3 years following the acquisition of the Bank's shares by PZU SA and PFR in the first stage of the Transaction.

 

In the SPA, PZU SA and PFR agreed with the Seller the terms of the non-compete prohibition applicable to the Seller and entities from the Seller's capital group, as well as the principles of non-solicitation of the Bank's key employees.

 

Given the need to ensure a seamless spin-off of the Bank from the Seller's capital group, the Parties anticipate concluding an agreement regulating the basic rules of the spin-off (in the context of IT) of the Bank from the Seller's capital group. This agreement will specify the rules, in particular with regard to ensuring continuity of processes based on the IT systems possessed by the Bank, and will also regulate the rules and costs associated with ensuring the Bank's self-sufficiency after the Transaction is completed in thecontext of access to services and rights to software.

 

Moreover, the Parties agreed that their intention is that Pioneer Pekao Investment Management S.A. (and through this, indirectly, Pioneer Pekao TFI S.A.), Pekao Pioneer PTE S.A. and Dom Inwestycyjny Xelion Sp. z o.o. will fully belong to the Bank's capital group. As a result, the SPA contains general, term sheet terms of the acquisition of the shares of the above-mentioned entities, which at the date of singing of the SPA belong to the Seller (or entities from the Seller's group) and not to the Bank.

 

It was agreed that maximum purchase price for the above-mentioned shares of Pioneer Pekao Investment Management S.A., Pekao Pioneer PTE S.A. and Dom Inwestycyjny Xelion Sp. z o.o. will not exceed a total of PLN 634 000 000 (six hundred thirty four million zloty), and these shares will be acquired for this price either by the Bank or PZU SA or an entity indicated by PZU SA. As a rule, it is not provided for an adjustment of the purchase prices, save for an automatic reduction of the total sale prices by the value of the dividends paid to the Seller or entities from the its group. PZU SA will publicly disclose information about realization of the acquisition transaction of the above-mentioned entities in current reports.

 

In connection with the SPA, on 8 December 2016 PZU and PFR concluded a consortium agreement. The consortium agreement sets out the mutual rights and obligations of PZU SA and PFR regarding the conducting and closing of the Transaction and the mutual cooperation between PZU and PFR in connection with the SPA and the Transaction (the "Consortium Agreement").

 

In turn, before the acquisition of the Bank's shares in the first stage, PZU SA and PFR will conclude a shareholders' agreement setting out the principles of cooperation of PZU SA and PFR after the completion of the Transaction and the parties obligations as the Bank's shareholders, in particular with respect to the joint exercising of the voting rights attached to the Bank's shares held (the "SHA").

 

The Sale Agreement, the Consortium Agreement and the SHA are governed by Polish law.

 

Legal basis: art. 17 section 1 of MAR - confidential information. "

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQAKFDNDBDDQBK
Date   Source Headline
8th Dec 20203:40 pmRNSDates of financial report releases in year 2021
20th Nov 20204:47 pmRNSAmendments to the Statute of Bank Pekao SA
5th Nov 20207:00 amRNS3rd Quarter Results
15th Oct 202012:36 pmRNSLetter from the BGF on establishing the MREL
2nd Oct 20201:27 pmRNSNotification on disposal of Bank's phantom shares
30th Sep 20201:21 pmRNSMaintaining ratings and Outlook of Pekao by Fitch
12th Aug 202010:38 amRNSNotification on acquisition of phantom shares
12th Aug 202010:37 amRNSNotifications on acquisitions and disposals shares
5th Aug 20209:22 amRNSHalf-year Report
17th Jun 20207:00 amRNSAppointment of the Vice President of the MB
17th Jun 20207:00 amRNSNon-financial information
8th Jun 20207:00 amRNSInformation provided to a shareholder outside GM
2nd Jun 20207:00 amRNSResignation of Vice-President of Management Board
1st Jun 20207:00 amRNSThe update with regards to impact of the COVID-19
29th May 20206:24 pmRNSAppointment of Presidium of the Supervisory Board
28th May 20207:14 amRNSAmendments to the Statute of Bank
27th May 20207:00 amRNSResolutions of the Ordinary General Meeting
27th May 20207:00 amRNSCorrection of report 33/2020 – Resolutions of OGM
26th May 20207:00 amRNSShareholders holding at least 5% of votes at OGM
26th May 20207:00 amRNSAppointment of members of the Supervisory Board
26th May 20207:00 amRNSResolution re distribution of net profit of Bank
22nd May 20207:00 amRNSCandidates to the Supervisory Board of Bank Pekao
22nd May 20207:00 amRNSDraft resolution for OGM submitted by shareholder
22nd May 20207:00 amRNSAmendments of the Statute of Bank
20th May 20208:13 amRNSResignations of members of the Supervisory Board
14th May 20207:00 amRNSCandidate to the Supervisory Board of Bank Pekao
12th May 202011:25 amRNS1st Quarter Results
7th May 20204:54 pmRNSA change of the agenda of the OGM of Bank
7th May 20204:50 pmRNSUpdate - impact of coronavirus COVID-19 epidemic
7th May 20201:11 pmRNSCandidates to the Supervisory Board of Bank
27th Apr 202010:44 amRNSAnnouncement on convening the OGM of the Bank
22nd Apr 20207:00 amRNSMr. Grzegorz Janas -the Chairman of the SB of Bank
22nd Apr 20207:00 amRNSChanges in the Management Board of the Bank
22nd Apr 20207:00 amRNSProposed distribution of net profit for 2019
17th Apr 20207:00 amRNS1Q'20 - change of publication date
17th Apr 20207:00 amRNSResignation of the Chairman of the SB of the Bank
15th Apr 202011:25 amRNSRevision of outlook to Negative of Bank by Fitch
15th Apr 20207:00 amRNSAppointment of the Vice Presidents of the MB
15th Apr 20207:00 amRNSBFG inf. on annual contribution to resolution fund
8th Apr 202011:10 amRNSRevision of outlook to stable by S&P GlobalRatings
30th Mar 20207:00 amRNSAviva OFE above 5% of total number votes in Bank
26th Mar 20203:54 pmRNSPFSA letter reg. retention of entire profit earned
26th Mar 20207:00 amRNSBlackRock, Inc. notific. reducing the voting share
26th Mar 20207:00 amRNSImpact of coronavirus COVID19 epidemic on activity
12th Mar 20207:00 amRNSAgreement with trade unions on redundancies
5th Mar 20204:57 pmRNSRecommendation of the PFSA regarding the dividend
20th Feb 20205:01 pmRNSIntended collective redundancies
5th Feb 20206:21 pmRNSAppointment of the Vice President of the MB
5th Feb 20206:17 pmRNSMr. Marek Lusztyn as the President of the MB
30th Jan 20206:02 pmRNSBlackRock, Inc. notification on above 5%

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.